ArticleInflammopharmacology2023

Oridonin attenuates the progression of atherosclerosis by inhibiting NLRP3 and activating Nrf2 in apolipoprotein E-deficient mice.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.